Adlai Nortye Ltd
ANLBuild a strategy around ANL
Adlai Nortye Ltd AI Insights
Informational only. Not investment advice.Snapshot
- Zero revenue pre-commercial biotech burning 52.9M TTM with only 60.9M cash - roughly 14 months runway at current burn rate[Cash and Equivalents]
- R&D spend of 44.9M TTM is 85% of operating expenses - high science focus but no revenue to fund it[Research and Development]
- Debt/equity of 1.07 with 26.3M current debt vs 25.5M equity - balance sheet stress for pre-revenue company[Debt to Equity]
Watch Triggers
- Cash and Equivalents: Falls below 40M or burn rate exceeds 15M/quarter — Sub-12mo runway triggers emergency financing at distressed terms
- Issuance of Capital Stock: Any equity raise announcement — Dilution timing and terms signal management's view of pipeline value
- Research and Development: Drops below 35M annually — R&D cuts signal pipeline prioritization or funding crisis
Bull Case
EV of only 10.4M vs 60.9M cash implies market assigns negative value to pipeline - any clinical success creates asymmetric upside
P/B of 1.73 with 25.4M tangible book - trading near liquidation value provides downside floor if pipeline fails
Bear Case
14-month cash runway with 26.3M current debt means dilution or default is near-certain without clinical catalyst
ROE of -203% and ROIC of -98% TTM - destroying capital at unsustainable rate with no path to profitability visible
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage ANL's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Cash runway exhaustion likely forces dilutive financing or partnership within 12-18 months
- 52M annual cash burn vs 60.9M cash
- Zero revenue with no near-term commercialization
- 26.3M current debt coming due
Valuation Context
Caveats
ANL Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$360.03M | — | ||
$378.35M | — | ||
0.00 | — | ||
$5.0M | — | ||
$-1.11 | — | ||
-714% | -714.0% | — | |
-711% | -710.6% | — | |
$-33.64M | — | ||
0% | — | ||
Beta 5Y (Monthly) | unknown | — |
ANL Dividend History
ANL Stock Splits
ANL SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
04/10/26 | 12/31/25 | Unknown | |
06/30/25 | 06/30/25 | Unknown | -- |
05/12/25 | 12/31/24 | 20-F/A | |
04/30/25 | 12/31/24 | 20-F | |
06/30/24 | 06/30/24 | 6-K | |
09/29/23 | 06/30/23 | 424B4 | |
08/10/23 | 03/31/23 | F-1/A | |
06/30/22 | 06/30/22 | Unknown | -- |
08/10/23 | 03/31/22 | F-1/A |